These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 7274623)
1. In vitro carcinogenesis of hepatocytes obtained from acetylaminofluorene-treated rat liver and promotion of their growth by phenobarbital. Kitagawa T; Watanabe R; Kayano T; Sugano H Gan; 1980 Dec; 71(6):747-54. PubMed ID: 7274623 [TBL] [Abstract][Full Text] [Related]
2. Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Peraino C; Staffeldt EF; Haugen DA; Lombard LS; Stevens FJ; Fry RJ Cancer Res; 1980 Sep; 40(9):3268-73. PubMed ID: 7427940 [No Abstract] [Full Text] [Related]
3. Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. Watanabe K; Williams GM J Natl Cancer Inst; 1978 Nov; 61(5):1311-4. PubMed ID: 280716 [TBL] [Abstract][Full Text] [Related]
4. Nonlinearities in 2-acetylaminofluorene exposure responses for genotoxic and epigenetic effects leading to initiation of carcinogenesis in rat liver. Williams GM; Iatropoulos MJ; Wang CX; Jeffrey AM; Thompson S; Pittman B; Palasch M; Gebhardt R Toxicol Sci; 1998 Oct; 45(2):152-61. PubMed ID: 9848122 [TBL] [Abstract][Full Text] [Related]
6. Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver. Kraupp-Grasl B; Huber W; Putz B; Gerbracht U; Schulte-Hermann R Cancer Res; 1990 Jun; 50(12):3701-8. PubMed ID: 1971196 [TBL] [Abstract][Full Text] [Related]
7. Frequency and DNA content of micronuclei in rat parenchymal liver cells during experimental hepatocarcinogenesis. Van Goethem F; Ghahroudi MA; Castelain P; Kirsch-Volders M Carcinogenesis; 1993 Nov; 14(11):2397-406. PubMed ID: 8242871 [TBL] [Abstract][Full Text] [Related]
8. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver. Tatematsu M; Nagamine Y; Farber E Cancer Res; 1983 Nov; 43(11):5049-58. PubMed ID: 6137276 [TBL] [Abstract][Full Text] [Related]
9. [Characteristics of hepatocarcinogenesis after single exposure of synchronized cells of the regenerating liver to N-nitrosodiethylamine and subsequent administration of phenobarbital]. Osipova LA; Vinarchuk MP; Khranovskaia LN; Bykorez AI Eksp Onkol; 1987; 9(5):61-4. PubMed ID: 3691396 [TBL] [Abstract][Full Text] [Related]
10. Dose-response relationship for the promoting effect of phenobarbital on the induction of liver hyperplastic nodules in rats exposed to 2-fluorenylacetamide and carbon tetrachloride. Takano T; Tatematsu M; Hasegawa R; Imaida K; Ito N Gan; 1980 Aug; 71(4):580-1. PubMed ID: 7429095 [No Abstract] [Full Text] [Related]
11. Choline enhances acetylaminofluorene promotion of liver carcinogenesis in female but not in male rats. Tessitore L; Pani P; Dianzani MU Carcinogenesis; 1992 Mar; 13(3):385-9. PubMed ID: 1547527 [TBL] [Abstract][Full Text] [Related]
12. Effects of the tumor promoter 2-acetylaminofluorene and of 4-acetylaminofluorene on rat liver growth. Gerlyng P; Seglen PO Bull Cancer; 1990; 77(5):461-6. PubMed ID: 2400817 [TBL] [Abstract][Full Text] [Related]
13. Modification of the development of N-nitrosomorpholine-induced hepatic lesions by 2-acetylaminofluorene, phenobarbital and 4,4'-diaminodiphenylmethane: a sequential histological and histochemical analysis. Ito N; Moore MA; Bannasch P Carcinogenesis; 1984 Mar; 5(3):335-42. PubMed ID: 6705139 [TBL] [Abstract][Full Text] [Related]
14. Hepatic foci of cellular and enzymatic alteration and nodules in rats treated with clofibrate or diethylnitrosamine followed by phenobarbital: their rate of onset and their reversibility. Greaves P; Irisarri E; Monro AM J Natl Cancer Inst; 1986 Mar; 76(3):475-84. PubMed ID: 2869179 [TBL] [Abstract][Full Text] [Related]
15. Early initiating and promoting effects in 2-AAF-induced rat liver carcinogenesis: an immunohistochemical study. Hadjiolov N; Bitsch A; Neumann HG Cancer Lett; 1995 Nov; 98(1):39-46. PubMed ID: 8529204 [TBL] [Abstract][Full Text] [Related]
16. Strain differences in susceptibility to 2-acetylaminofluorene and phenobarbital promotion of hepatocarcinogenesis: immunohistochemical analysis of cytochrome P-450 isozyme induction by 2-acetylaminofluorene and phenobarbital. Asamoto M; Tsuda H; Kato T; Ito N; Masuko T; Hashimoto Y; Nagase S Jpn J Cancer Res; 1989 Nov; 80(11):1041-6. PubMed ID: 2514165 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Maeura Y; Weisburger JH; Williams GM Cancer Res; 1984 Apr; 44(4):1604-10. PubMed ID: 6704970 [TBL] [Abstract][Full Text] [Related]
18. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cattley RC; Popp JA Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380 [TBL] [Abstract][Full Text] [Related]
19. Promotion by dietary phenobarbital of hepatocarcinogenesis by 2-methyl-N,N-dimethyl-4-aminoazobenzene in the rat. Kitagawa T; Pitot HC; Miller EC; Miller JA Cancer Res; 1979 Jan; 39(1):112-5. PubMed ID: 104788 [TBL] [Abstract][Full Text] [Related]
20. Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation. Gerlyng P; Grotmol T; Seglen PO Carcinogenesis; 1994 Feb; 15(2):371-9. PubMed ID: 7508825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]